Tumor-specific aggregation of magnetic liposome nanoparticles in tumor-bearing mice after ultrasound-guided intratumor injection of liquid-solid phase-change biomagnetic material
Basic Medicine|更新时间:2026-01-09
|
Tumor-specific aggregation of magnetic liposome nanoparticles in tumor-bearing mice after ultrasound-guided intratumor injection of liquid-solid phase-change biomagnetic material
Journal of Third Military Medical UniversityVol. 42, Issue 20, Pages: 1995-2002(2020)
作者机构:
1.400016 重庆,重庆医科大学超声影像学研究所,超声分子影像重庆市重点实验室
2.200025 上海,上海交通大学医学院附属瑞金医院超声科
3.400010 重庆,重庆医科大学第二附属医院超声科
4.200233 上海,上海交通大学附属第六人民医院超声科,上海超声医学研究所
作者简介:
基金信息:
the International-Regional Cooperation and Exchange Program of National Natural Science Foundation of China(81720108023);the National Natural Science Foundation for Young Scholars of China(81801699)
Junnian HAO, Ronghui WANG, Haitao RAN, et al. Tumor-specific aggregation of magnetic liposome nanoparticles in tumor-bearing mice after ultrasound-guided intratumor injection of liquid-solid phase-change biomagnetic material[J]. Journal of Third Military Medical University, 2020, 42(20): 1995-2002.
DOI:
Junnian HAO, Ronghui WANG, Haitao RAN, et al. Tumor-specific aggregation of magnetic liposome nanoparticles in tumor-bearing mice after ultrasound-guided intratumor injection of liquid-solid phase-change biomagnetic material[J]. Journal of Third Military Medical University, 2020, 42(20): 1995-2002. DOI: 10.16016/j.1000-5404.202004297.
Tumor-specific aggregation of magnetic liposome nanoparticles in tumor-bearing mice after ultrasound-guided intratumor injection of liquid-solid phase-change biomagnetic material
To prepare ultrasound-guided intratumor injection of liquid-solid phase-transition biomagnetic material (NdFeB/Fe
3
O
4
/PLGA
NFP) and investigate its feasibility and efficiency of aggregating for targeted aggregation of intravenously injected magnetic liposome nanoparticles (MLPs).
Methods
2
The biomagnetic material NFP was prepared and its liquid-solid phase transition ability
morphology and magnetization performances were assessed; the form
particle size and diameter of MLPs were also characterized. The biocompatibility of NFP and MLPs were evaluated by cytotoxic proliferation experiments
and the efficiency of MLP capture by NFP was determined using an
in vitro
model of extracorporeal circulation. A 4T1 mouse model bearing breast cancer xenograft was established
in which NFP was injected in the tumor under ultrasound guidance and MLPs conjugated with a fluorescent dye was injected intr
avenously by tail vein. The efficiency of NFP implant for capturing the MLPs for targeted aggregation of the latter in the xenograft was evaluated using
in vivo
fluorescence imaging.
Results
2
The biomagnetic material NFP capable of liquid-solid phase transition was successfully prepared. Scanning electron microscopy and elemental mapping results showed a homogeneous distribution of the elements in NFP after phase transition. The NFP implant could be efficiently magnetized
in vitro
and the magnetic forces of NFP was positively correlated with its volume (350.14±23.89
493.47±19.54
679.39±34.23
and 812.36±27.99 Gs for 25
50
75
and 100 μL of NFP
respectively). The prepared MBLs had a uniform particle size of 373.658±50.000 nm with a zeta potential of -24.8±2.5 mV. Cytotoxicity experiments with tumor cells and normal cells showed no obvious cytotoxicity of either NFP or MLPs.
in vivo
fluorescence imaging showed that following intravenous MLB injection and intratumor NFP implantation
the fluorescence intensity was significantly enhanced in the xenografts in the tumor-bearing mice.
Conclusion
2
The prepared liquid-solid phase-change biomagnetic NFP and the MLPs have good biocompatibility. NFP implantation in the tumor can efficiently capture intravenously injected MLPs to achieve targeted aggregation of MLPs in the tumors.
关键词
Keywords
references
MASOOD F. Polymeric nanoparticles for targeted drug delivery system for cancer therapy[J]. Mater Sci Eng C Mater Biol Appl, 2016, 60: 569-578. DOI: 10.1016/j.msec.2015.11.067.
SHI J, KANTOFF P W, WOOSTER R, et al . Cancer nanomedicine: progress, challenges and opportunities[J ] . Nat Rev Cancer, 2017, 17(1): 20-37. DOI: 10.1038/nrc.2016.108.
MAEDA H, WU J, SAWA T, et al . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review[J ] . J Control Release, 2000, 65(1/2): 271-284.
WILHELM S, TAVARES A J, DAI Q, et al . Analysis of nanoparticle delivery to tumours[J ] . Nat Rev Mater, 2016, 1(5): 16014. DOI: 10.1038/natrevmats.2016.14.
RIVIÈRE C, MARTINA M S, TOMITA Y, et al . Magnetic targeting of nanometric magnetic fluid loaded liposomes to specific brain intravascular areas: a dynamic imaging study in mice[J ] . Radiology, 2007, 244(2): 439-448. DOI: 10.1148/radiol.2442060912.
LVBBE A S, BERGEMANN C, RIESS H, et al . Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors[J ] . Cancer Res, 1996, 56(20): 4686-4693.DOI: 1996Oct 15;56(20):4686-93.
SHAPIRO B, KULKARNI S, NACEV A, et al . Open challenges in magnetic drug targeting[J ] . WIREs Nanomed Nanobiotechnol, 2015, 7(3): 446-457. DOI: 10.1002/wnan.1311.
MIRZABABAEI S N, GORJI T B, BAOU M, et al . Investigation of magnetic nanoparticle targeting in a simplified model of small vessel aneurysm[J ] . J Magn Magn Mater, 2017, 426: 126-131. DOI: 10.1016/j.jmmm.2016.11.044.
GOODWIN S, PETERSON C, HOH C, et al . Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy[J ] . J Magn Magn Mater, 1999, 194(1/3): 132-139. DOI: 10.1016/s0304-8853(98)00584-8.
TAKEDA S-I, MISHIMA F, FUJIMOTO S, et al . Development of magnetically targeted drug delivery system using superconducting magnet[J ] . J Magn Magn Mater, 2007, 311(1): 367-371. DOI: 10.1109/tasc.2007.898413.
TANG X Z, WANG L C, GAO W, et al . PLGA-NdFeB-Fe3O4 implant for magnetic hyperthermia of mice bearing breast cancer[J ] . Chin J Interv Imaging Ther, 2018, 15(6): 351-356. DOI: 10.13929/j.1672-8475.201801012.
CHEN Y, JIANG L, WANG R H, et al . Injectable smart phase-transformation implants for highly efficient in vivo magnetic-hyperthermia regression of tumors[J ] . Adv Mater Deerfield Beach Fla, 2014, 26(44): 7468-7473. DOI: 10.1002/adma.201402509..
ZHENG Y Y , KRUPKA T, WU H P, et al . Direct measurement of blood flow velocity in small diameter vessels using contrast-enhanced ultrasound[J ] . Ultrasound Med Biol, 2009, 35(8): S16. DOI: 10.1016/j.ultrasmedbio.2009.06.063.
ROY H S, ZUO G Q, LUO Z C, et al . Direct and Doppler angle-independent measurement of blood flow velocity in small-diameter vessels using ultrasound microbubbles[J ] . Clin Imaging, 2012, 36(5): 577-583. DOI: 10.1016/j.clinimag.2012.01.026.